Trials / Unknown
UnknownNCT00396396
Role of Acetylcysteine in Creatinine Clearance
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (planned)
- Sponsor
- Eastern Virginia Medical School · Academic / Other
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the exact role of Acetylcysteine (Mucomyst) in altering creatinine clearance. Prior studies have shown the protective effects of Acetylcysteine on contrast-induced renal dysfunction. In these studies, Acetylcysteine lowered the incidence of serum creatinine elevation after administration of radiographic contrast agents. Not only was the increase in serum creatinine prevented, the studies also demonstrated a significant increase in creatinine clearance after administration of the agent. These prior studies did not evaluate if the increase in creatinine clearance was indeed from a protective benefit of Acetylcysteine in preserving the GFR versus simply increasing the proximal tubular creatinine secretion without actually affecting the GFR. We propose an experiment to help support our hypothesis that Acetylcysteine increases creatinine clearance via an increase in proximal tubular secretion of creatinine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acetylcysteine |
Timeline
- Start date
- 2006-10-01
- First posted
- 2006-11-06
- Last updated
- 2006-11-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00396396. Inclusion in this directory is not an endorsement.